Huwiler A, Staudt G, Kramer R M, Pfeilschifter J
Department of Pharmacology, Biozentrum, University of Basel, Switzerland.
Biochim Biophys Acta. 1997 Oct 18;1348(3):257-72. doi: 10.1016/s0005-2760(97)00073-8.
Incubation of rat glomerular mesangial cells with potent proinflammatory cytokines like interleukin 1beta, (IL- 1beta) triggers the expression of a non-pancreatic secretory phospholipase A2 (sPLA2) and increases the formation of prostaglandin E2. We show here that sPLA2 acts in an autocrine fashion on mesangial cells and induces a rapid activation of protein kinase C (PKC) isoenzymes delta and epsilon and of p42 mitogen-activated protein kinase (MAPK), two putative activators of cytosolic phospholipase A2 (cPLA2). sPLA2 also activates Raf-1 kinase in mesangial cells which integrates the signals coming from PKC for further processing along the MAPK cascade. Subsequently a phosphorylation and activation of cPLA2 is observed, thus arguing for a cross-talk between the two classes of PLA2. Pretreatment of cells with either the highly specific PKC inhibitor Ro-318220 or the highly specific MAPK kinase (MEK) inhibitor PD 98059 completely blocked the sPLA2-induced cPLA2 activation, indicating that both kinases are essential for the cross-talk between the two types of PLA2. The effect of sPLA2 is mimicked by lysophosphatidylcholine (LPC), a reaction product of sPLA2 activity. LPC stimulates PKC-epsilon, Raf-1 kinase and MAPK activation as well as cPLA2 activation with a subsequent increase in arachidonic acid release from mesangial cells. These data suggest that sPLA2 by cleaving membrane phospholipids and generating LPC and other lysophospholipids activates cPLA2 via the PKC/Raf-1/MAPK signalling pathway. Hence a network of interactions between different PLA2s is operative in mesangial cells and may contribute to the progression of glomerular inflammatory processes.
用白细胞介素1β(IL - 1β)等强效促炎细胞因子孵育大鼠肾小球系膜细胞,会引发非胰腺分泌型磷脂酶A2(sPLA2)的表达,并增加前列腺素E2的生成。我们在此表明,sPLA2以自分泌方式作用于系膜细胞,诱导蛋白激酶C(PKC)同工酶δ和ε以及p42丝裂原活化蛋白激酶(MAPK)快速激活,这两种酶是胞质磷脂酶A2(cPLA2)的假定激活剂。sPLA2还激活系膜细胞中的Raf - 1激酶,该激酶整合来自PKC的信号,以便沿着MAPK级联进行进一步处理。随后观察到cPLA2的磷酸化和激活,因此表明两类磷脂酶A2之间存在相互作用。用高度特异性的PKC抑制剂Ro - 318220或高度特异性的MAPK激酶(MEK)抑制剂PD 98059预处理细胞,可完全阻断sPLA2诱导的cPLA2激活,表明这两种激酶对于两类磷脂酶A2之间的相互作用至关重要。溶血磷脂酰胆碱(LPC)可模拟sPLA2的作用,LPC是sPLA2活性的反应产物。LPC刺激PKC - ε、Raf - 1激酶和MAPK激活以及cPLA2激活,随后系膜细胞中花生四烯酸释放增加。这些数据表明,sPLA2通过裂解膜磷脂并生成LPC和其他溶血磷脂,经由PKC/Raf - 1/MAPK信号通路激活cPLA2。因此,不同磷脂酶A2之间的相互作用网络在系膜细胞中起作用,可能有助于肾小球炎症过程的进展。